Equities

Uni-Bio Science Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Uni-Bio Science Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.111
  • Today's Change0.003 / 2.78%
  • Shares traded4.22m
  • 1 Year change+81.97%
  • Beta0.1264
Data delayed at least 15 minutes, as of Feb 06 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Uni-Bio Science Group Ltd is an investment company mainly engaged in the manufacture and sales of pharmaceutical products. The Company operates its business through three segments. Biological Pharmaceutical Products segment is mainly engaged in the manufacture and sale of biological pharmaceutical products. Chemical Pharmaceutical Products segment is mainly engaged in the manufacture and sale of chemical pharmaceutical products. Pipeline Products segment is mainly engaged in the research and development of pharmaceutical products.

  • Revenue in HKD (TTM)589.59m
  • Net income in HKD91.35m
  • Incorporated2001
  • Employees504.00
  • Location
    Uni-Bio Science Group Ltd13/F, Public Bank Centre,120 Des Voeux Road Central, Central Hong KongHKG
  • Phone+852 31023232
  • Fax+852 31023737
  • Websitehttps://www.uni-bioscience.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wai Yuen Tong Medicine Holdings Ltd721.27m-13.83m388.16m726.00--0.32815.240.5382-0.0123-0.01230.64111.050.41651.419.68950,292.50-0.7998-1.81-1.06-3.1049.8744.67-1.92-11.190.7806--0.2033---4.923.73126.62-56.1631.89--
China NT Pharma Group Co Ltd21.00m-79.82m532.65m21.00------25.37-0.2315-0.23150.0485-0.46220.0546--3.09954,470.30-20.76-10.31----51.27---380.13-97.110.0447-0.39737.95--415.34-24.38-59.32---71.03--
Fusen Pharmaceutical Co Ltd271.22m-196.93m547.08m1.05k--1.40--2.02-0.2664-0.26640.36690.52760.18751.114.05239,807.00-13.62-2.83-32.04-5.4041.3951.61-72.61-8.000.4241-0.43440.5137---42.36-4.36-420.39---17.55--
Modern Chinese Medicine Group Co Ltd227.57m21.36m576.00m190.0022.470.878516.642.530.03560.03560.37930.91070.3925.897.491,197,711.003.6814.833.9317.5624.5738.449.3817.927.8021.300.00032.85-37.78-0.4333-80.18-26.87112.81--
Zhongzhi Pharmaceutical Holdings Ltd2.26bn23.13m595.88m2.49k25.170.48764.160.26380.02740.02742.681.421.052.666.45876,430.901.096.771.6810.4757.1959.641.035.911.0651.800.113438.978.0510.54-41.51-3.6513.6210.79
Uni-Bio Science Group Ltd589.59m91.35m644.89m504.007.091.685.631.090.01520.01520.09760.06411.133.629.181,210,657.0017.516.2122.178.5682.1980.7215.494.963.2259.390.221,633.5814.0821.4316.79102.0432.65--
Pak Fah Yeow International Ltd199.03m70.97m747.94m100.0010.541.069.643.760.22770.22770.63862.260.22271.8424.741,877,594.007.945.038.685.2487.4482.2335.6623.926.217.720.006894.02-8.649.89-25.1416.8816.37-8.84
Lee's Pharmaceutical Holdings Ltd1.44bn97.81m883.25m1.04k9.030.45454.390.61490.16610.16612.443.300.51812.649.171,405,524.002.3213.852.9918.2453.1059.374.4835.220.71117.990.11792.9732.952.81457.55-5.81-10.46-4.28
Data as of Feb 06 2026. Currency figures normalised to Uni-Bio Science Group Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.16%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 08 Jan 20268.00m0.13%
Voya Investments LLCas of 31 Dec 20251.34m0.02%
DFA Australia Ltd.as of 30 Nov 20254.28k0.00%
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.